Implantable nanosensor for early-stage ovarian cancer detection

Ended Project Grant Awarded Last action

Award ID
W81XWH2210563
Recipient
Awarding agency
Obligated
$1,347,700

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $673,850.00 Federal
  • $673,850.00 Non-federal
Place of performance
New York, NY 10065, USA

Award details come from USAspending.gov.

About this award

The Department of the Army Medical Command awarded a $1,347,700 Project Grant to Sloan-Kettering Institute For Cancer Research under the Military Medical Research and Development program (CFDA 12.420). The grant will support development of an implantable nanosensor for early-stage ovarian cancer detection from June 2022 through June 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will further those goals by funding research into a novel nanosensor that could enable earlier detection of ovarian cancer, improving patient outcomes. The total funding amount of $1,347,700 will support Sloan-Kettering's work developing this promising early detection technology over the three-year period of performance in New York, New York.

Quick answers

Who received award W81XWH2210563?

W81XWH2210563 was awarded to Sloan-Kettering Institute For Cancer Research by Medical Command (Department of the Army) on June 15, 2022.

How much is award W81XWH2210563 worth?

$1,347,700 has been obligated on W81XWH2210563: $673,850 in federal funding and $673,850 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award